Immune checkpoint inhibitor trials for Lung cancer

All Immune checkpoint inhibitor trials · All Lung cancer trials

Phase breakdown

Recruiting trials studying Immune checkpoint inhibitor for Lung cancer

• Chemotherapy With or Without Immune Checkpoint Inhibitors for Lung Cancer
  NCT05059951 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer
  NCT06730503 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• ICI Rechallenge for Advanced NSCLC With Long-Term Response to First-Line ICI
  NCT06388031 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
  NCT05522660 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 15 locations
• Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study
  NCT07405086 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer
  NCT04913311 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location

Common questions

How many trials study Immune checkpoint inhibitor for Lung cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.